breast
cancer
common
caus
mortal
approxim
breast
cancer
hormon
although
endocrin
therapi
remain
effect
treatment
efficaci
limit
intrins
acquir
endocrin
tamoxifen
select
er
modul
common
endocrin
therapi
worldwid
henc
resist
tamoxifen
major
clinic
challeng
solid
tumor
breast
cancer
usual
contain
heterogen
popul
neoplast
cell
immun
cell
collect
resid
recruit
stromal
cell
type
togeth
form
relev
tumor
heterogen
link
variou
hallmark
cancer
includ
drug
macrophag
divers
cell
show
distinct
phenotyp
depend
anatom
locat
activ
breast
cancer
macrophag
compris
among
macrophag
commonli
refer
tam
associ
tumor
scaveng
receptor
regard
highli
specif
monocytemacrophag
marker
escamilla
et
al
report
tam
involv
resist
patient
prostat
cancer
androgen
blockad
previou
studi
found
correl
tam
tamoxifen
resist
patient
breast
cancer
underli
mechan
macrophag
secret
varieti
chemokin
tme
includ
secret
mainli
macrophag
cocultur
also
known
small
induc
cytokin
belong
cc
chemokin
famili
recruit
monocyt
memori
cell
dendrit
cell
site
sever
studi
report
inflammatori
environ
promot
malign
behavior
differ
xu
et
al
found
recruit
monocyt
tme
polar
macrophag
secret
also
import
manifest
tam
polar
ueno
et
al
show
high
level
express
signific
indic
earlier
howev
studi
role
endocrin
resist
breast
cancer
molecular
mechan
underli
endocrin
resist
breast
cancer
highli
complic
involv
mani
molecul
pathway
overexpress
epiderm
growth
factor
receptor
andor
mutat
er
loss
activ
mapk
signal
overexpress
cytochrom
among
factor
activ
signal
pathway
domin
thota
et
al
observ
induct
endocrin
resist
tumor
macrophag
although
intrins
molecular
mechan
remain
aim
present
studi
explor
interact
tam
phenotyp
breast
cancer
cm
breast
cancer
cell
test
abil
induc
macrophag
polar
examin
role
tam
promot
tamoxifen
resist
also
identifi
specif
cytokin
secret
tam
promot
endocrin
resist
investig
underli
mechan
action
immunohistochemistri
carri
patholog
section
patient
invas
breast
cancer
examin
correl
express
diseas
prognosi
find
understand
tam
promot
tamoxifen
resist
breast
cancer
cell
may
identifi
novel
therapeut
target
patient
breast
cancer
tam
recombin
human
synthesi
inhibitor
bindarit
pma
purchas
antibodi
nuclear
factor
kappa
b
compon
pathway
purchas
boster
purchas
invitrogen
breast
cancer
cell
line
human
monocyt
cell
line
purchas
type
cultur
collect
chines
academi
scienc
maintain
medium
supplement
fb
cell
obtain
treat
cell
nmoll
tam
month
cell
grown
fb
nmoll
tam
maintain
resist
tamoxifen
cell
prolifer
assess
use
vazym
assay
accord
manufactur
instruct
briefli
cell
seed
plate
densiti
cellswel
incub
tamoxifen
hour
end
respect
incub
time
cell
incub
complet
medium
contain
reagent
hour
subsequ
absorb
sampl
measur
nm
micropl
reader
tecan
experi
repeat
three
time
ms
mr
human
macrophag
grown
small
cultur
dish
fix
paraformaldehyd
minut
follow
wash
pb
thrice
cell
block
bsa
minut
incub
antibodi
dilut
overnight
signal
detect
use
alexa
fluor
secondari
antibodi
invitrogen
sampl
imag
use
axioskop
mot
plu
fluoresc
microscop
equip
plan
apochromat
na
na
object
axiocam
mrc
camera
axiovis
softwar
carl
zeiss
total
rna
extract
ms
mr
macrophag
use
trizol
reagent
rna
revers
transcrib
cdna
use
revers
transcriptas
vazym
quantit
pcr
done
use
sybr
green
detect
kit
cwbio
detect
system
rel
gene
express
normal
macrophag
express
primer
target
gene
list
tabl
tumor
necrosi
factor
tnf
present
cultur
supernat
ms
mr
macrophag
quantifi
use
specif
elisa
kit
quantikin
human
immunoassay
quantikin
human
immunoassay
r
system
follow
manufactur
instruct
concentr
sampl
estim
standard
curv
level
detect
limit
assay
record
zero
breast
cancer
cell
suspend
fb
concentr
cellsml
annexin
iodid
pi
stain
cell
transfer
flow
cytomet
tube
dilut
pb
centrifug
g
minut
supernat
remov
decant
blot
sampl
pellet
suspend
bind
buffer
annexin
ad
sampl
incub
dark
minut
flow
cytomet
analysi
bind
buffer
pi
ad
sampl
flow
cytometri
analysi
pi
green
fluoresc
dot
plot
annexin
orang
fluoresc
macrophag
wash
pb
pe
mous
bd
pharmingen
use
analyz
polar
macrophag
cell
filter
resuspend
buffer
sort
analys
conduct
facsdiva
version
cell
lyse
ripa
buffer
protein
sampl
sonic
follow
centrifug
g
minut
supernat
collect
protein
concentr
determin
use
bradford
assay
protein
lysat
subject
sd
page
transfer
onto
pvdf
membran
accord
manufactur
instruct
invitrogen
membran
block
salin
tween
hour
follow
incub
primari
antibodi
overnight
follow
day
membran
wash
thrice
incub
secondari
antibodi
cell
signal
hour
protein
express
visual
ecl
chemiluminesc
promega
quantifi
use
imag
j
softwar
nation
cancer
institut
micropor
membran
pore
size
transwel
insert
costar
use
chemotaxi
assay
briefli
cell
ad
upper
chamber
cm
ms
mr
mr
bindarit
ad
lower
chamber
cell
allow
migrat
hour
atmospher
air
insert
fix
stain
crystal
stain
solut
cell
remov
membran
mount
migratori
cell
observ
count
microscop
protocol
studi
approv
ethic
committe
harbin
medic
univers
cancer
hospit
conform
provis
declar
helsinki
breast
cancer
specimen
obtain
harbin
medic
univers
cancer
hospit
patient
sign
inform
consent
form
medic
record
review
tissu
sampl
donat
decemb
june
patient
breast
cancer
enrol
retrospect
studi
slide
incub
antibodi
dilut
biosourc
intern
antibodi
dilut
novocastra
yellow
granul
indic
posit
immunoreact
score
stain
intens
neg
weak
moder
strong
stain
percentag
posit
tumor
cell
per
core
tissu
consid
posit
express
stain
intens
cell
examin
yellow
granul
indic
posit
immunoreact
score
infiltr
densiti
macrophag
rang
absent
dens
score
equal
greater
regard
posit
data
express
mean
sd
statist
analys
carri
use
graphpad
prism
softwar
version
spss
statist
softwar
version
multipl
comparison
evalu
use
anova
correl
determin
use
spearman
correl
surviv
curv
analyz
use
method
curv
compar
use
test
multivari
surviv
analysi
use
cox
regress
proport
hazard
model
carri
adjust
clinic
variabl
may
statist
signific
prognosi
univari
analysi
result
p
valu
consid
statist
signific
p
p
cell
first
differenti
macrophag
treatment
nm
pma
hour
cm
cell
ad
anoth
hour
cultur
figur
final
obtain
two
type
tam
tam
tme
ms
tam
tme
mr
examin
differ
macrophag
cellular
immunofluoresc
flow
cytometri
analysi
carri
ms
mr
consid
polar
maker
tam
found
cm
breast
cancer
cell
line
increas
express
indic
polar
express
higher
polar
signific
mr
ms
figur
c
observ
indic
macrophag
polar
assum
differ
phenotyp
differ
microenviron
investig
function
macrophag
differ
phenotyp
supernat
macrophag
ms
mr
ad
cell
hour
obtain
ms
mr
cell
figur
cell
treat
tamoxifen
apoptot
flow
cytometri
analysi
carri
cell
viabil
assess
use
assay
figur
f
signific
resist
tamoxifen
observ
cell
cultur
cm
tam
ms
mr
mr
tamoxifen
resist
thu
conclud
increas
polar
tam
increas
abil
resist
apoptosi
promot
endocrin
resist
cancer
cell
promot
polar
macrophag
turn
promot
cancer
cell
hypothes
differ
abil
tam
promot
endocrin
resist
due
differ
level
secret
cytokin
review
relev
literatur
select
seven
cytokin
interleukin
il
may
promot
endocrin
resist
breast
cancer
transcript
seven
cytokin
three
macrophag
ms
mr
assess
identifi
cytokin
whose
transcript
level
consist
trend
apoptot
flow
cytometri
assay
consist
previou
result
differ
statist
signific
figur
also
abil
promot
endocrin
resist
transcript
ms
mr
differ
howev
result
show
transcript
ms
statist
signific
secret
could
explain
differ
ms
promot
drug
resist
endocrin
tumor
therefor
chosen
main
object
present
studi
exclud
effect
autocrin
cancer
cell
measur
express
level
cell
elisa
detect
signific
level
determin
concentr
cm
three
macrophag
polar
macrophag
concentr
secret
increas
significantli
concentr
posit
correl
trend
endocrin
resist
cell
figur
thu
conclud
associ
endocrin
resist
promot
tam
two
hormon
cell
line
select
test
effect
confirm
receptor
express
cell
line
figur
nmml
ad
two
cell
line
cell
cultur
hour
subsequ
tamoxifen
ad
four
group
cell
cultur
hour
cell
viabil
assess
use
assay
figur
four
group
also
analyz
flow
cytometri
detect
apoptosi
figur
f
found
promot
endocrin
resist
reduc
apoptot
proport
two
hormon
cell
line
shown
associ
endocrin
resist
cell
line
signal
pathway
classic
pathway
regul
cell
prolifer
apoptosi
endocrin
resist
investig
effect
activ
pathway
cell
treat
nmoll
phosphoryl
akt
mtor
significantli
increas
ad
cm
mr
cell
also
activ
signal
pathway
mr
treat
nmoll
bindarit
synthesi
inhibitor
abil
cm
mr
bindarit
increas
level
phosphoryl
akt
mtor
weaken
figur
result
suggest
tam
promot
endocrin
resist
breast
cancer
cell
partli
secret
activ
pathway
secret
thought
depend
transcript
factor
activ
test
whether
breast
cancer
cell
macrophag
produc
elisa
cm
cm
cm
cm
ms
cm
mr
found
could
secret
low
concentr
supernat
breast
cancer
cell
promot
autocrin
secret
macrophag
howev
signific
differ
level
cm
ms
cm
mr
cm
cm
figur
analysi
activ
pathway
ms
mr
show
activ
pathway
tam
signific
activ
pathway
ms
mr
statist
signific
figur
result
explain
differ
secret
ms
mr
pathway
sens
amino
acid
chang
cm
regul
express
independ
signal
dephosphoryl
transcript
factor
test
activ
pathway
ms
mr
found
activ
pathway
consist
secret
trend
figur
result
suggest
amino
acid
metabol
cm
activ
pathway
tam
promot
secret
chemokin
abundantli
present
macrophag
respons
recruit
concentr
posit
correl
potenti
alreadi
determin
level
secret
ms
mr
differ
next
question
whether
chemotaxi
cell
induc
three
macrophag
coincid
secret
result
chemotaxi
assay
confirm
effect
tam
toward
cell
stronger
macrophag
effect
mr
stronger
ms
bindarit
inhibitor
revers
enhanc
chemotaxi
abil
mr
figur
valid
phenomenon
vitro
analyz
tissu
sampl
patient
breast
cancer
immunohistochemistri
serial
patholog
section
show
high
express
paraneoplast
stroma
correl
infiltr
macrophag
r
p
figur
tabl
propos
tumor
cell
stimul
polar
macrophag
lead
increas
secret
high
concentr
turn
promot
aggreg
form
macrophag
determin
clinic
relev
endocrin
resist
vitro
find
select
patient
invas
breast
cancer
receiv
regular
endocrin
therapi
tumor
hospit
harbin
medic
univers
tabl
patholog
section
stain
immunohistochemistri
paraneoplast
stromal
area
observ
microscopi
patient
high
express
develop
relaps
progress
median
pf
month
patient
low
express
develop
relaps
progress
median
pf
month
pf
curv
base
express
paraneoplast
stroma
figur
b
result
show
pf
group
significantli
shorter
group
p
prognost
valu
clinicopatholog
featur
assess
use
cox
hazard
regress
analysi
express
found
independ
risk
factor
surviv
df
hr
p
tabl
taken
togeth
result
indic
crucial
role
promot
endocrin
resist
breast
cancer
endocrin
resist
breast
cancer
major
clinic
challeng
treat
patient
resist
diseas
present
studi
mechan
endocrin
resist
focus
breast
cancer
cell
studi
focus
role
cell
tme
tam
import
compon
tme
play
role
angiogenesi
metastasi
tumor
previou
studi
confirm
tam
correl
tamoxifen
resist
patient
breast
present
studi
investig
mechan
underli
endocrin
resist
breast
cancer
cell
show
breast
cancer
cell
induc
polar
tam
tam
turn
promot
endocrin
resist
breast
cancer
cell
found
breast
cancer
cell
secret
trace
amount
promot
autocrin
secret
macrophag
therebi
activ
pathway
promot
releas
breast
cancer
cell
activ
pathway
macrophag
alter
amino
acid
metabol
environ
promot
polar
secret
macrophag
also
found
tam
promot
endocrin
resist
secret
activ
signal
pathway
therefor
play
import
role
malign
feedback
loop
addit
promot
aggreg
monocyt
macrophag
transit
monocyt
tam
promot
format
microenviron
analysi
tissu
sampl
patient
hormon
breast
cancer
confirm
correl
high
express
paraneoplast
stroma
infiltr
macrophag
moreov
patient
high
express
stroma
shorter
pf
endocrin
therapi
consist
find
previou
studi
patient
high
macrophag
infiltr
tend
develop
endocrin
find
promot
format
tme
malign
cycl
cell
tme
may
partli
explain
patient
endocrin
resist
past
like
resist
new
endocrin
therapi
macrophag
adjust
phenotyp
function
respons
local
cue
provid
crosstalk
tam
cancer
cell
complex
involv
exosom
cytokin
present
studi
focus
cytokin
secret
macrophag
examin
role
endocrin
resist
breast
cancer
cell
found
activ
pathway
classic
endocrin
resist
pathway
howev
direct
mechan
activ
pathway
determin
anoth
limit
present
studi
due
long
cultur
time
cell
line
effect
cell
line
macrophag
could
repeat
cell
compon
tme
complex
addit
tam
fibroblast
dendrit
cell
epitheli
cell
neutrophil
lymphocyt
also
tame
tumor
cell
promot
tumor
malign
report
dendrit
cell
fibroblast
epitheli
cell
tame
cancer
cell
secret
cell
also
contribut
posit
feedback
loop
howev
studi
role
cell
endocrin
resist
breast
cancer
report
effect
breast
cancer
cell
differenti
cell
futur
research
focu
effect
cell
compon
tme
endocrin
resist
breast
cancer
conclus
result
indic
tumor
cell
like
promot
polar
macrophag
wherea
tam
promot
endocrin
resist
tumor
cell
thu
form
posit
feedback
loop
tam
breast
cancer
cell
figur
play
import
role
posit
feedback
loop
increas
secret
tam
activ
pathway
tumor
cell
promot
endocrin
resist
format
microenviron
aggreg
monocyt
tme
find
suggest
tam
may
potenti
novel
therapeut
target
patient
breast
cancer
author
declar
conflict
interest
articl
